Biocatalyst portfolio overview 

Johnson Matthey manufactures a comprehensive range of biocatalysts to support the development of pharmaceuticals, agrochemicals, and other fine chemicals from initial screening to commercial-scale supply. Our enzyme portfolio complements our chemo-catalyst technology, providing a versatile and effective approach to synthesizing key chiral intermediates. 

In addition to our commercial enzymes, we also customize them for your specific application. Our biocatalysis expertise ensures an optimized and scalable process for the production of chiral compounds. 

Advantages of JM biocatalyst portfolio

Diversity

Unlock maximum enzyme diversity with our novel wildtypes, cherry-picked mutants, and in silico-designed variants. Selected for their unique substrate scopes. 

Process ready 

Our process expertise and 10 years of R&D have been used to validate and optimize our enzyme collection. Our enzymes are fit for purpose and ready to perform in demanding environments. 

Scalable supply

We specialise in scaling enzyme production from kits to large-volume. Our experts collaborate to optimise processes and address the challenges of scaling up. 

Reductive amination 

Amine dehydrogenase

Imine reductase

Transaminase

C=C reduction

ENE reductase

C=O reduction

Alcohol dehydrogenase

Cofactor regeneration

Formate dehydrogenase

Glucose dehydrogenase

Alcohol dehydrogenase

Equilibrium shift 

Alanine dehydrogenase

Lactate dehydrogenase

Get in touch

Send us a message to request a quote or ask our advice. We'd be happy to hear from you.